Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-04

Clinical Trial Update: The ROB-OSTIAL Study [NA]

View source ↗

Summary

The ROB-OSTIAL trial, sponsored by Corindus Inc., in coronary artery disease has been terminated. Results were posted on 2025-06-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Corindus Inc. | Conditions: Coronary Artery Disease | NA | Status: TERMINATED | Results posted: 2025-06-04